FDA
approval
· 2023-07-31
FDA Approved: SAXAGLIPTIN AND METFORMIN — Original Application (Mylan Pharmaceuticals Inc.)
Summary
The FDA approved the original application for a generic fixed-dose combination of saxagliptin and metformin (SAXAGLIPTIN AND METFORMIN) from Mylan Pharmaceutica…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for SAXAGLIPTIN AND METFORMIN (SAXAGLIPTIN AND METFORMIN)